WFDC2 and ovarian carcinoma: In 2019, Hellstrom et al. [45] published an interesting study describing the results obtained by using four different anti-HE4 mouse antibodies (mAbs) to characterize the different isoforms of the HE4 protein in ovarian cancer cells and in the blood of women affected by these neoplasms.